Martin Cowie, HRC 2019 – Beta-blockers in patients with AF and heart failure


We were delighted to meet with Martin Cowie (Atrial Fibrillation Association Medical Advisory Committee Member and Trustee), who spoke about the role of beta-blockers in patients with atrial fibrillation and heart failure, and the topical subject of anti-coagulation – the topic of his presentation at HRC 2019.

Speaker Disclosures: Martin Cowie discloses research grants from Bayer, ResMed, Abbott, Boston Scientific and Medtronic, and provides consultancy advice to Bayer, ResMed, Abbott, Boston Scientific, Medtronic, Novartis, Servier, Fire1Foundry, Neurotronik, AstraZeneca and Boehringer Ingelheim.

1. Are beta-blockers of benefit in patients with atrial fibrillation and heart failure? (0:08)
And do we even anticoagulate appropriately? (1:20) is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.

Filmed at the Heart Rhythm Congress (HRC) 2019 in Birmingham, UK, October 2019 in partnership with Arrhythmia Alliance.